Healthy Skepticism Library item: 6724

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mongeau JG.
Weighing benefits and risks of drug to treat obesity
Canadian Medical Association Journal 1997; 156:769

Abstract:

The authors of the New England Journal of Medicine editorial should answer for themselves. Sukkari’s comments about the monograph in the United States is out-of-date. The European community now authorizes the long term use of dexfenfluramine.

Keywords:
*letter to the editor/Canada/Servier/dexfenfluramine/Redux/obesity/European Union/PROMOTION DISGUISED: PRESS CONFERENCES AND PRESS COVERAGE